Key Takeaways
- A bank loan for a cancer hospital is assessed on promoter strength, realistic project cost, revenue model and DSCR; bed count or land area alone does not determine loan eligibility.
- Banks typically finance hospital building, interiors, radiotherapy infrastructure and medical equipment through term loan or equipment finance, while medicines, salaries and receivables are covered through separate working capital limits.
- A detailed DPR integrating project cost, financial projections, working capital assessment and repayment schedule is essential for cancer hospital project finance; weak assumptions or incomplete documentation are the primary reasons proposals get delayed or rejected.
- This article, written by CA Manish Gugliya (ProjectReportBank.com), walks through each step of structuring finance, preparing a cancer hospital project report for bank loan and demonstrating repayment capacity.
- Readers will find categorised checklists of cancer hospital loan documents, an explanation of DSCR, sensitivity analysis and a simplified numerical example useful while planning their oncology centre.
Explore Cancer Hospital DPR Guides
Explore our complete series on Cancer Hospital project planning, financial analysis and bank finance.
Introduction: Bank Finance for Cancer Hospital & Oncology Centre in India
India records over 1.4 million new cancer cases annually, and the demand for dedicated oncology hospitals continues to rise across Tier-1 and Tier-2 cities. Cancer treatment costs can push families into poverty; out-of-pocket expenses for cancer treatment have climbed to nearly 50% in India, and roughly 30% of cancer patients rely on borrowing to cover treatment costs. Cancer treatment abandonment rates remain high due to financial constraints, with treatment consuming 40-50% of GDP per capita for many patients. This burden creates an urgent need for accessible, well-equipped cancer hospitals; yet many districts still lack advanced radiotherapy equipment.
Setting up a cancer hospital involves heavy investment in land, civil construction, radiotherapy bunkers, LINAC machines, imaging, bone marrow transplant units, ICUs and diagnostics. Depending on bed capacity and city tier, total project cost can range from ₹60 crore for a focused oncology centre to ₹150 crore or more for a comprehensive cancer hospital. Banks in India actively provide cancer hospital project finance, but they appraise the project on promoter profile, detailed project cost, realistic revenue model and loan repayment capacity, not merely on the value of land or equipment.
This article is written in first person by CA Manish Gugliya, Chartered Accountant, sharing practical insights from preparing DPRs, CMA data, financial projections and DSCR analysis for bank term loans across healthcare projects. The focus here is on structuring a bank loan for a cancer hospital or oncology centre. While many patients access financial assistance through schemes and NGOs (the Indian Cancer Society’s Cancer Cure Fund has disbursed Rs. 341.14 crores for over 18,000 patients since inception; the fund can sanction up to Rs. 5 lakh per patient; the Dr. Arun Kurkure Fund provides Rs. 25,000 for initial cancer treatment for needy cancer patients, with over 17,000 patients receiving initial treatment funding since 2014; the HMDG scheme offers Rs. 5 lakhs for eligible patients with low income; the Prime Minister’s Relief Fund aids in paying for cancer treatments; and the chief minister’s relief fund, health minister’s discretionary grant and Ayushman Bharat cover major illnesses like cancer for low-income families), this article addresses the project-level financing required to actually build and equip such institutions. NGOs like the Indian Cancer Society provide financial aid directly to partner hospitals, not to patients individually; applicants submit documentation including Aadhaar card, income certificate and medical reports, often requiring a letter of reference from their doctor. Patients need to submit financial and medical documentation to NGOs, and financial aid applications require proof of income and medical records. NGOs also assist with free accommodation and food for cancer patients undergoing treatment. Financial assistance is available for patients with family income under Rs. 4 lakh at an ICS empanelled hospital. These patient-level realities shape the revenue environment in which a cancer hospital operates.
Types of Bank Finance for Cancer Hospital – Term Loan, Equipment Finance & Working Capital
Securing bank loans for cancer hospitals involves specialised healthcare financing structures. Banks typically split the finance into three buckets: a term loan for fixed assets, dedicated equipment finance for high-cost machines and working capital finance for ongoing operations. Combinations are common; a promoter might take the primary cancer hospital term loan from a PSU bank, arrange separate vendor-backed equipment finance for a LINAC or PET-CT, and set up a cash credit or overdraft facility for day-to-day operational liquidity from the same or another lender.
| Type of Finance | Purpose | Typical Items Financed |
|---|---|---|
| Term Loan | Creating fixed assets | Hospital building, radiation bunkers, interiors, electrical, HVAC, DG sets, medical gas pipeline, furniture, basic equipment |
| Equipment Finance | Acquiring high-cost medical machinery | LINAC, brachytherapy unit, PET-CT, MRI, CT scan, OT and ICU equipment, diagnostics |
| Working Capital | Funding operational expenses | Medicines, chemotherapy drugs, consumables, salaries, utilities, receivables management |
Product structure, margins, interest rate and collateral depend on lender policy, project risk profile and promoter strength. No uniform norms apply across all banks.
Term Loan for Cancer Hospital – What Can Be Financed?
A hospital term loan is long-term project finance used to create the fixed assets required for oncology services. Term loans are typically used for large-scale capital expenditure. In my experience, the DPR should present a clear line-item cost statement so that the bank can identify which items fall under term loan funding and which are equity-funded.
Capital expenditure components that lenders commonly consider:
- Civil construction of hospital building and radiation bunkers (shielded to AERB specifications)
- Interior fit-outs for OPD, IPD, OT complex, ICU, HDU, chemo day-care
- Electrical installations, LT/HT panels, DG sets
- HVAC and chiller plants
- Medical gas pipeline system and centralised oxygen
- Lifts and vertical transportation
- Fire-fighting and safety systems
- Hospital furniture and fixtures
- Basic IT, networking and HMIS servers
- Eligible pre-operative expenses, consultancy and interest during construction
Land purchase is treated differently: some lenders fund land partially, but many prefer that land is brought in primarily from promoter contribution. Always verify each bank’s policy before structuring the cost statement.
Repayment tenures for cancer hospital term loans commonly range around 8-15 years including moratorium. For example, a Delhi super-specialty hospital project had a loan tenure of 13 years including moratorium. The DPR and project cost statement should clearly segregate items eligible for term loan versus those funded from equity to avoid appraisal confusion.
Medical Equipment Finance for Oncology – LINAC, PET-CT & Others
Oncology facilities require intensive capital investment for high-end equipment. Equipment financing is designed for acquiring costly diagnostic and therapeutic machinery, and it often operates as a separate facility with its own terms, tenure and security.
Typical oncology and hospital equipment that may be financed:
- Linear accelerator (LINAC) with IMRT/IGRT/VMAT capability
- Brachytherapy unit
- CT simulator and radiotherapy planning systems
- PET-CT scanner
- MRI and CT machines
- Digital mammography for breast cancer screening
- Chemo mixing hoods and laminar flow units
- OT tables and anaesthesia workstations
- ICU ventilators and monitors
- Pathology and diagnostic lab equipment
Equipment loans may have shorter tenure than building loans, often 5-7 years, sometimes with balloon payments matching expected cash accrual from radiotherapy and imaging services. As a reference, Salem Medical College Hospital recently acquired a LINAC for approximately ₹22.96 crore and a brachytherapy unit for ₹4 crore. A single LINAC, depending on complexity, costs between ₹12 crore and ₹20 crore before import duty and site preparation.
Banks review equipment quotations for OEM reputation, warranty, AMC/CMC terms, technology obsolescence risk and service support availability. For detailed equipment planning, refer to Cancer Hospital Equipment List & Cost in India.
Working Capital Finance for Cancer Hospital Operations
A fully constructed cancer hospital still needs adequate working capital to buy medicines and chemotherapy drugs, pay salaries, meet utility bills and manage receivables from TPAs, insurers and government schemes. Working capital loans are used to manage day-to-day operational liquidity.
Key working capital items include:
- Inventory of oncology medicines and consumables
- High-cost chemotherapy vials, targeted therapy drugs and immunotherapy agents
- Disposables for day-care, OT and radiology
- Salaries for oncologists, resident doctors, nurses, paramedical and administrative staff
- Power, oxygen and medical gas expenses
- Maintenance contracts, housekeeping and security
- Receivables from insurance coverage, government health schemes and corporate clients
- Co payment reconciliation delays from TPA settlements
The distinction is clear: capex finance (term loan/equipment finance) builds the hospital; working capital finance (CC/OD, short-term WC loan, bank guarantees, LCs for drug procurement) keeps it running. Banks typically assess working capital using projected operating cycle and may apply methods like Nayak norms for smaller limits. Oncology hospitals with high drug inventory and longer TPA settlement cycles often need customised assessment. For step-by-step calculation, see Cancer Hospital Working Capital Requirement & Assessment.
Cancer Hospital Project Cost – Components & Role in Loan Appraisal
Total cancer hospital project cost is the foundation of project finance appraisal. It determines the term loan amount, promoter contribution and DSCR. Government-backed cancer hospital projects run into hundreds of crores: for example, Homi Bhabha Cancer Hospital, Muzaffarpur was built at ₹570 crore, and the Acharya Harihar Regional Cancer Centre in Cuttack spent ₹30 crore on LINAC machines and ₹17 crore on the LINAC complex alone.
Major project cost heads include:
- Land (where applicable)
- Hospital building and civil construction including radiation bunkers
- Interiors and medical planning
- Oncology and general medical equipment
- Electrical systems and DG sets
- HVAC and chillers
- Medical gas pipeline and oxygen plant
- Furniture and fixtures
- IT infrastructure and HMIS
- Preliminary and pre-operative expenses
- Contingencies
- Margin for working capital
- Interest during construction (where relevant)
Underestimation of project cost, especially radiotherapy shielding and statutory compliance-related works, is a common reason for cost overrun and additional funding challenges. Cost break-up must be consistent between DPR, architect BOQ, equipment quotations and CMA data to avoid doubts at the bank’s credit committee. For detailed costing benchmarks, refer to Cancer Hospital Project Cost in India.
Means of Finance & Promoter Contribution Structure
After finalising project cost, the next step is structuring means of finance: how much will come from promoter equity, bank term loan, equipment finance and other sources.
Typical components:
- Promoter contribution or equity (including fixed deposits, personal savings, group company funds)
- Unsecured subordinated loans from promoters or group entities (if accepted by the bank)
- Term loan for civil construction and core assets
- Equipment finance from banks or NBFCs
- Margin for working capital
- Grants, budgetary support or corpus fund contributions if the project is under a charitable trust
Banks look for adequate promoter commitment through the debt-equity ratio. In a Delhi super-specialty hospital case, the debt-equity split was roughly 58:42, meaning promoter equity was about 42%. The exact promoter margin percentage varies by lender, risk rating and collateral strength; there is no universal norm. For smaller oncology centres, the CGTMSE provides guarantee coverage to eligible loans made to smaller enterprises, reducing collateral burden. Internationally, SBA loans are backed by government programs to reduce risk for banks; in India, credit guarantee schemes serve a similar role for eligible borrowers.
Trusts running not-for-profit cancer hospitals may have donations or a fund’s corpus earmarked for cancer care, along with generous support from donors. Banks will still check long-term sustainability and repayment capacity. Deductions under the Income Tax Act (such as Section 80G or Section 11/12 for trusts) may improve the entity’s financial resources but do not substitute for cash-flow-based repayment ability.
For syndicated loans involving multiple banks pooling resources for large projects, the means of finance structure becomes more complex and typically applies to very large cancer institutes or research centres. See Cancer Hospital Project Cost & Means of Finance for expanded discussion.
Medical Equipment Selection, Cost and Its Impact on Bank Finance
Oncology equipment decisions (single vs dual energy LINAC, PET-CT capacity, MRI slice count, domestic vs imported) directly influence project cost, loan size and DSCR. In my experience, equipment selection is one of the most sensitive variables in cancer hospital project finance.
Key considerations:
- Updated quotations from OEMs with clear scope of supply
- Inclusion of installation, shielding and site preparation in quoted price
- Customs duty and GST implications for imported equipment
- Comparison of imported vs Indian equipment on cost and capability
- AMC/CMC commitments and annual maintenance escalation
- Expected useful life and technology obsolescence risk
- Spares availability and uptime guarantees
- Capacity utilisation assumptions for radiotherapy and imaging
Banks cross-check whether proposed equipment configuration matches projected patient load, catchment area demographics and availability of oncologists. Over-investment in very high-end equipment without realistic cancer patient volumes may strain loan repayment even if clinical quality is excellent. For indicative planning details, review Cancer Hospital Equipment List & Cost in India.
Revenue Model for Oncology Hospital – Beyond Bed Count
Lenders do not rely only on “number of beds multiplied by average revenue per bed.” Banks seek realistic patient volume and revenue assumptions in loan proposals, built around actual oncology services and treatment mix.
Revenue streams to model:
- OPD consultation across medical, surgical and radiation oncology
- Chemotherapy day-care and in-patient chemotherapy cycles
- Radiotherapy sessions on LINAC and brachytherapy
- Surgical oncology procedures (breast cancer surgery, GI, urological, gynaecological)
- IPD room rent and ICU charges for adult patients and pediatric patients
- Diagnostics and imaging (CT, MRI, PET-CT, initial diagnostic tests)
- Pathology and molecular diagnostic tests
- In-house pharmacy margins
- Palliative care and pain management services
- Emergency treatment and related charges
Projections should capture phased ramp-up in patient volumes, realistic IPD bed occupancy, gradually increasing utilisation of LINAC and PET-CT and payer mix including cash, insurance, government schemes and corporate tie-ups. Ayushman Bharat covers cancer treatment for economically weaker sections and low-income families. State governments also run health schemes. Out-of-pocket expenses for many patients remain around 50%, and NGOs like the Indian Cancer Society provide financial aid through their Cancer Cure Fund directly to hospitals. About 30% of cancer patients rely on borrowing, affecting hospital bills and collection cycles.
These assumptions must be supported by catchment-area cancer incidence, referral linkages with government hospitals and smaller facilities and brand-building timelines. Arbitrary “80-90% occupancy from Year 1” will not pass credit appraisal. For methodology, see Cancer Hospital Revenue Model.
Financial Projections Required for Cancer Hospital Bank Loan
Banks expect integrated 7-10 year financial projections covering P&L, Balance Sheet and Cash Flow along with key ratios for cancer hospital project finance.
Main projection components:
- Detailed income statement showing oncology revenue streams and operating expenses
- Projected Balance Sheet with fixed assets, term loans, working capital and equity
- Cash Flow Statement capturing cash accrual and debt servicing
- Depreciation schedule aligned to asset classes (building, equipment, furniture, IT)
- Interest calculations based on projected loan drawdown schedule
- Working capital estimation consistent with inventory and receivable cycles
Key financial indicators: EBITDA margin, net profit margin, cash accrual, DSCR, break-even year and payback period. All assumptions (bed occupancy, number of chemotherapy cycles, radiotherapy fractions per machine, average bill size) must be consistent throughout DPR, projections and CMA data. Banks also examine treatment options offered and match them with projected procedure volumes to test credibility. For detailed methodology, see Cancer Hospital Financial Projections for DPR & Bank Loan.
Working Capital Requirement & Assessment for Cancer Hospitals
Oncology hospitals, though service-oriented, have substantial funds locked in inventory and receivables, making working capital planning critical for financial viability. Many patients receive medical treatment funded through insurance or government schemes, and settlement from these channels takes 30-90 days or more.
Typical working capital cycle components:
- Average stock of chemotherapy and targeted therapy drugs (often high-value)
- Surgical and radiology consumables
- Average receivable period from insurance companies, TPAs and government schemes
- Credit period from pharma suppliers and equipment vendors
- Monthly salary and overhead outflows
- Minimum cash balance for unforeseen needs
A projection of at least one full year’s month-wise working capital cycle is useful for determining peak requirement and structuring CC/OD limits. Inadequate working capital is a common cause of stress in early stage operations; hospitals may delay vendor payments, postpone salary payouts or compromise on critical drugs, which ultimately affects treatment quality. Hospital bills may pile up as receivables, creating financial stress. For stepwise calculation, see Cancer Hospital Working Capital Requirement & Assessment.
DSCR & Repayment Capacity in Cancer Hospital Project Finance
Debt Service Coverage Ratio (DSCR) measures the ability to service term loan and interest from project cash accrual. The formula:
DSCR = Cash available for debt servicing / (Interest + Principal repayment) for the year
How banks look at DSCR:
- Year-wise DSCR across the full loan tenure
- Average DSCR over the repayment period (many banks require average around 1.5x or higher; Bank of Baroda’s Arogyadham scheme requires average DSCR of 1.75x with minimum 1.25x in any year)
- Minimum DSCR during ramp-up years
- Impact of moratorium period on early-year coverage
- Behaviour under downside scenarios
Lenders stress-test projections by lowering revenue or increasing costs to see how DSCR behaves, especially for high-cost radiotherapy and imaging-heavy projects. A project showing accounting profit can still experience repayment stress if cash flows and principal repayments are mismatched. For further detail, refer to Cancer Hospital DSCR & Loan Repayment Capacity.
DPR for Cancer Hospital Bank Loan – Contents & Practical Approach
A Detailed Project Report (DPR) is the key document combining technical, medical, operational and financial details into a single proposal for lenders. A detailed business plan is required to secure a bank loan for a cancer hospital; a generic profile will not suffice.
Key DPR sections:
- Executive summary focused on the project and proposed loan
- Promoter and management background (doctors, oncologists, healthcare entrepreneurs, social workers contributing to governance)
- Project concept, location and site details
- Bed mix and configuration
- Proposed oncology departments: medical, surgical, radiation oncology, bone marrow transplant unit, day-care chemotherapy, palliative care
- Market assessment, catchment area analysis and competition mapping
- Infrastructure and equipment plan covering common cancers treated
- Implementation schedule and project milestones
- Detailed project cost and means of finance
- Revenue assumptions and payer mix (cash, insurance, government schemes, especially those serving poor patients and underprivileged patients)
- Operating cost assumptions including manpower, drugs, consumables
- Financial projections and ratios
- Working capital assessment
- DSCR and repayment schedule
- Sensitivity analysis and risk-mitigation strategies
A well-prepared DPR reduces queries from credit teams and speeds up appraisal for cancer hospital term loan and working capital loan. The DPR should be lender-oriented with clear logic and justifications. Institutions like Tata Memorial Hospital and the National Cancer Institute have set clinical benchmarks, and a DPR for a private hospital should reflect awareness of such patients’ treatment expectations and standards. ProjectReportBank.com prepares oncology-specific DPRs integrating technical planning, project cost and DSCR analysis for bank submission.
Documents Generally Required for Cancer Hospital Loan
Exact documentation requirements vary by bank, NBFC and scheme, but promoters can prepare a standard set to minimise delays. Financial statements from the past three years are required for established facilities expanding into oncology.
| Document Category | Examples | Why Bank Requires It |
|---|---|---|
| Promoter / KYC | PAN, Aadhaar, address proof, CV, net-worth statement, ITRs (3 years), bank statements | Verifies identity, financial strength and capital sources |
| Entity Documents | Registration/incorporation certificate, trust deed or MoA/AoA, GST registration, Udyam (if applicable), board/trustee resolutions | Confirms legal status and borrowing authority |
| Project Documents | Land ownership/lease deed, building plans, architect BOQ, equipment quotations, AERB in-principle approval, DPR | Establishes project scope, cost and regulatory readiness |
| Financial Documents | Audited financials, existing loan details, CMA data, projected financial statements, repayment schedule | Enables credit appraisal of viability and repayment capacity |
Banks typically evaluate existing liabilities and credit history when assessing loans. Regulatory approvals, including AERB clearance for radiotherapy, building permits, fire safety and Pollution Control Board consent, are needed for a cancer hospital to secure financing. While initial sanction may proceed with in-principle approvals, disbursement is usually linked to key licences. Documentation for underprivileged cancer patients accessing financial aid through hospital-linked NGO programs (including income certificate and medical reports) is a separate process from the project-level loan documentation covered here.
Security, Collateral & Guarantees in Oncology Hospital Loans
Healthcare project finance in India generally requires creation of primary security and, in many cases, additional collateral and guarantees. Collateral may include property or high-end medical equipment.
Primary security:
- Mortgage or charge over hospital land and building
- Hypothecation of medical equipment, radiotherapy machines, diagnostics and other movable fixed assets
- Charge over receivables for working capital facilities
Collateral and guarantees:
- Additional residential or commercial property mortgage
- Charge over other assets of the trust or company where required
- Assignment of key-man insurance or term policies in some cases
- Personal guarantees of key promoters or trustees
- Corporate guarantees of group entities where relevant
Security structure should be transparently presented in the loan proposal. Existing encumbrances and realistic valuation expectations must be disclosed. For hospital projects where FACR (Fixed Asset Coverage Ratio) is 1.5 or above, some lenders may relax additional collateral requirements.
How Banks Actually Assess a Cancer Hospital Term Loan Proposal
From a lender’s perspective, the bank’s credit appraisal evaluates the clinical viability and cash flow predictability of the project. Technical feasibility and financial viability are key for cancer hospital project assessments. Credit teams assess promoter capability, project feasibility, security and DSCR together, not in isolation.
Promoter assessment: Clinical qualifications (for doctor-promoters), track record of running hospitals or oncology units, financial strength, governance quality and past repayment behaviour reflected in CIBIL or credit reports.
Project and market assessment: Suitability of location, catchment-area population and cancer incidence, existing competition (proximity to a cancer institute or research institute or research centre), referral network, projected patient volumes, planned bed mix and oncology services such as bone marrow transplant, palliative care and radiation therapy for many cancers and common cancers in the region. Allow patients from poor families, underprivileged patients and needy individuals to access care through government schemes and providing financial assistance programs, which affects revenue-mix assumptions.
Financial appraisal: Reasonableness of project cost, adequacy of promoter contribution, credibility of revenue assumptions, operating cost realism (especially salaries of oncologists and high medical expenses on consumables), DSCR (average and minimum), repayment tenure alignment with cash accrual and adequacy of working capital limits. The bank also checks treatment expenses benchmarked to comparable cancer care facilities.
Banks verify statutory and regulatory compliance, including AERB clearances, building approvals, fire safety and clinical registrations, before final sanction or disbursement.
Sensitivity Analysis & Risk Mitigation in DPR
A robust cancer hospital DPR should include sensitivity analysis rather than only a single optimistic base case.
Typical downside scenarios to model:
- Patient volumes 15-20% lower than projected
- Slower ramp-up in radiotherapy sessions or PET-CT scans
- Higher operating expenses (electricity, staff cost escalation)
- Capex overrun on equipment or civil works
- Longer receivable cycle from insurance companies or government schemes
For each scenario, impact on revenue, profitability, cash accrual and DSCR should be shown, helping both promoter and bank understand resilience of the project and its health outcomes under stress.
Practical risk-mitigation levers: phased commissioning of departments, tying up with insurance and TPAs in the early stage, staggered equipment procurement, creating internal contingency for cost escalation, raise funds through structured promoter infusion if needed and aligning repayment schedule with realistic cash flows.
Common Mistakes in Cancer Hospital Loan Proposals
Many oncology projects face delays or rework not because the medical concept is weak but due to avoidable financial and documentation mistakes.
Frequent errors I have observed:
- Overly aggressive revenue assumptions and bed occupancy projections from Year 1
- Ignoring lengthy approval timelines for AERB and building permits
- Underestimating project cost, especially radiotherapy shielding and bunker construction
- Inadequate provision for working capital and treatment fund for initial operations
- Mismatch between repayment schedule and cash-flow ramp-up period
- Inconsistencies between DPR narrative and financial projections
- Missing or outdated equipment quotations without AMC/CMC details
- Weak justification of catchment area and patient volumes (no data on cancer incidence, no referral analysis)
- Submitting generic hospital DPRs that do not reflect oncology-specific realities (for example, ignoring the cost of shielding for radiation therapy equipment)
- Insufficient promoter margin or unclear source of equity contribution
Running a pre-appraisal checklist covering these issues before sharing the project with banks improves acceptance chances. Involving a project finance professional early helps structure means of finance and DSCR before approaching multiple lenders.
Step-by-Step Process to Obtain Bank Loan for Cancer Hospital
A structured sequence reduces back-and-forth with banks and prevents major redesign late in the process.
- Conceptualising oncology centre and defining scope
- Preliminary market and feasibility assessment
- Freezing bed capacity and service mix (OPD, IPD, chemotherapy, radiation therapy, bone marrow transplant, diagnostics, palliative care)
- Estimating cancer hospital project cost
- Equipment planning and vendor discussions
- Structuring means of finance (equity, term loan, equipment finance, working capital)
- Preparing detailed revenue model and financial projections
- Assessing working capital requirement and DSCR
- Drafting integrated DPR
- Collating cancer hospital loan documents
- Submitting proposal to selected banks
- Responding to queries, site visits and clarifications
- Sanction, documentation and creation of security
- Phase-wise disbursement linked to project progress
Disbursements can be linked to milestones related to the project, such as completion of building structure, installation of radiotherapy equipment or receipt of AERB clearance. Timelines differ based on bank, project readiness and completeness of documents. Building a reasonable buffer in the project schedule for provide aid in handling unexpected delays is advisable. Simultaneous evaluation by two lenders (where permissible) can provide flexibility on terms, but the promoter must maintain information consistency across proposals.
Illustrative Example of Cancer Hospital Project Finance & DSCR
The following is a simplified numerical example using illustrative assumptions only. These are not standard ratios or industry benchmarks.
Assumptions (illustrative):
- 150-bed cancer hospital in a Tier-2 Indian city
- Total project cost: approximately ₹120 crore
- Land: ₹30 crore (mostly equity-funded)
- Building and interiors: ₹50 crore
- Equipment including LINAC and PET-CT: ₹35 crore
- Pre-operative, contingency and margin for working capital: ₹5 crore
Means of Finance (illustrative):
| Source | Amount (₹ Cr) | Share |
|---|---|---|
| Promoter contribution (equity + subordinated funds) | 45 | 37.5% |
| Bank term loan | 60 | 50% |
| Equipment finance | 10 | 8.3% |
| Internal accruals/other sources | 5 | 4.2% |
| Total | 120 | 100% |
Revenue and DSCR ramp-up (illustrative):
- Year 1: Modest occupancy and utilisation; cash accrual barely covers interest; DSCR around 0.9-1.0 (moratorium on principal)
- Year 2: Occupancy and radiotherapy sessions increase; DSCR improves to approximately 1.2
- Year 3-4: DSCR crosses 1.5 as chemotherapy cycles, radiation therapy fractions, diagnostic tests and surgical volumes stabilise
- Average DSCR over loan tenure: approximately 1.6-1.8
Such modelling helps decide moratorium period, repayment tenure and working capital limits before finalising loan structure. The numbers above are for illustration; every project requires its own assumptions based on location, services, equipment and promoter profile. Government employees, poor patients suffering from cancer, end stage cancer patients and adult patients from various income segments will form part of the payer mix, and projections should reflect this realistically.
Author’s Perspective – Role of Professional DPR & Financial Modelling
In my experience, successful cancer hospital project finance proposals are those where the medical concept, technical design, project cost, means of finance, projections and DSCR align into one coherent story. When a credit officer reads the DPR, every number should connect logically: equipment costs match vendor quotations, revenue projections match bed capacity and LINAC utilisation, and cash accrual covers debt service with a reasonable margin.
At ProjectReportBank.com, I focus on preparing oncology-specific DPRs, CMA data, financial projections, DSCR analysis and bank-finance proposals, ensuring each assumption is understandable to bankers. The objective is not only loan sanction but sustainable repayment capacity, so that the hospital can focus on quality cancer care, including services such as breast cancer treatment and screening, chemotherapy, radiation therapy and bone marrow transplant, without financial distress. Hospitals that achieve good health outcomes build reputation, which in turn supports revenue stability and debt servicing.
CA Manish Gugliya Chartered Accountant; Project Finance, DPR, CMA Data & Financial Modelling
Conclusion – Structuring a Bankable Cancer Hospital Loan Proposal
Obtaining a bank loan for a cancer hospital or oncology centre in India depends on more than collateral. Banks expect reasonable project cost, adequate promoter contribution, credible revenue projections, sufficient working capital and sustainable DSCR. A lender-oriented DPR, supported by realistic revenue model, working capital assessment and DSCR analysis, improves the quality and speed of project appraisal.
Promoters, doctors and healthcare entrepreneurs should invest time in planning and documentation before approaching banks, rather than modifying the project repeatedly after receiving queries. For professional assistance in preparing a cancer hospital project report for bank loan, DPR, CMA data, financial projections or DSCR analysis, promoters can connect via ProjectReportBank.com.
FAQs – Bank Loan for Cancer Hospital & Oncology Centre
Can a new doctor without previous hospital ownership get a bank loan for an oncology centre?
Yes, though the risk assessment will be tighter. A first-time promoter can strengthen the proposal by partnering with senior oncologists, demonstrating relevant clinical experience (for example, at a private hospital or cancer institute), showing adequate personal net worth and providing sufficient collateral. Banks evaluate the combined team’s capability, not only ownership history. Involving an experienced healthcare administrator or co-promoter can improve lender confidence.
Is it compulsory to have all regulatory approvals before applying for a cancer hospital term loan?
Initial sanction may proceed based on in-principle approvals, sanctioned building plans and land ownership. Final disbursement, however, is usually linked to key licences: building completion certificate, AERB clearance for radiotherapy equipment, fire safety NOC and health department registration. Promoters should begin the approval process in parallel with loan application to avoid disbursement delays. The bank may include specific approval milestones as conditions in the sanction letter.
Can separate loans be taken for land, building and radiotherapy equipment?
Some promoters structure multiple facilities across banks and NBFCs. For example, a PSU bank may fund the building through a term loan while an equipment finance company funds the LINAC and PET-CT. This approach can optimise interest cost and tenure but requires careful coordination of security creation and cash-flow allocation. Over-leverage is a real risk; total debt service across all facilities must remain within the project’s cash accrual capacity.
How long does it typically take from DPR submission to sanction for a cancer hospital loan?
Timelines range from a few weeks to several months depending on project size, completeness of documentation, bank’s internal processes and whether clarifications are needed. In my experience, proposals with a complete DPR, updated equipment quotations, clear land documents and consistent financial projections move through appraisal faster. Large projects requiring credit committee approval at regional or head-office level take longer than branch-level sanctions for smaller oncology units. New Delhi-based bank head offices may have different processing timelines than regional offices.
What is DSCR and why is it important in a cancer hospital loan proposal?
DSCR (Debt Service Coverage Ratio) measures whether the project’s annual cash accrual is sufficient to cover both interest and principal repayment for that year. A DSCR of 1.5 means the project generates 50% more cash than needed for debt servicing. Banks check year-wise DSCR, average DSCR and minimum DSCR. If DSCR falls below the bank’s threshold (often 1.25 in any single year), the loan proposal may face rejection or require restructured repayment terms. The ratio ensures that financial resources generated by the hospital are adequate for sustainable repayment.
Explore All Cancer Hospital DPR Guides
Continue exploring our complete series on Cancer Hospital project planning, financial projections, repayment capacity and bank finance.